Analysts revisit Humana stock price targets amid Medicare Advantage hit
Several Wall Street analysts adjusted their stock price targets for Humana after the earnings report. Oppenheimer analyst Michael Wiederhorn lowered the firm's price target on the company's shares to $370 from $415 while keeping an outperform rating on the stock.
Investors with a lot of money to spend have taken a bullish stance on Humana HUM. And retail traders should know. We noticed this today when the positions showed up on publicly available options ...
Humana’s stock turned lower Wednesday, after the health insurer reported a quarterly profit that beat expectations by a wide ...
Humana pulled back its growth projections for 2025 amid concerns about Medicare Advantage rates and demographic changes.
The health insurance company reported adjusted earnings of $7.23 a share, on revenue of $29.61 billion. Analysts had expected ...
The reported Humana Inc. merger with Cigna Group could have new life, according to a Jefferies analyst, who says the numbers ...
Humana shares dipped roughly 4% in early trading, even though the insurer beat Wall Street expectations in its first-quarter ...
Analysts have recently evaluated Humana and provided 12-month price targets. The average target is $371.6, accompanied by a ...
2don MSN
Toronto's Melissa Humana-Paredes and Brandie Wilkerson were the latest Canadian beach volleyball duo to fall to Esmee Bobner ...
A shortage in the availability of medical personnel across the United States continues to be a concern. Despite the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results